{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:49:28Z","timestamp":1791492568261,"version":"4.3.4"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007497","name":"Biosense Webster, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007497","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Johnson & Johnson MedTech"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Pulsed field ablation (PFA) is increasingly used for atrial fibrillation and is being extended beyond pulmonary vein isolation to right atrial (RA) and superior vena cava (SVC) targets. As its use expands, interactions with cardiac implantable electronic devices (CIEDs) have become an important yet incompletely defined safety concern. We aimed to evaluate context-dependent interactions between PFA and diverse CIED systems in a controlled pre-clinical model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Thirteen swine underwent implantation of contemporary CIED systems. Seven animals received PFA across multiple device configurations, including dual-chamber pacemakers, transvenous ICD\/CRT-D generator systems with single- or dual-coil ICD leads, a leadless ventricular pacemaker, and a subcutaneous ICD. Six control animals underwent catheter manipulation without energy delivery. PFA was performed in the left atrium (LA), RA, and SVC, including applications near transvenous leads and pre-specified delivery over exposed SVC defibrillator coils. Device parameters were assessed sequentially.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>When performed at an anatomical distance from device components, LA-PFA was not associated with critical device dysfunction under the studied conditions, although minor parameter changes occurred in a minority of cases, particularly with septal atrial lead positioning. During RA\/SVC procedures, parameter perturbations and atrial lead dislodgement were observed and were most consistent with catheter\u2013lead mechanical interaction. PFA delivered overexposed ICD coils that produced localized electrical changes without evidence of acute global device failure. The leadless ventricular pacemaker and subcutaneous ICD maintained stable function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PFA did not cause catastrophic CIED dysfunction under the studied conditions; however, device-PFA interactions were strongly context-dependent, influenced by anatomical proximity, conductive exposure, and mechanical interaction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjopen\/oeag124","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T11:11:26Z","timestamp":1786101086000},"source":"Crossref","is-referenced-by-count":0,"title":["Context-dependent interactions between variable-loop pulsed field ablation and cardiac implantable electronic devices: a controlled preclinical study"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8473-7514","authenticated-orcid":false,"given":"Masateru","family":"Takigawa","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Institute of Science Tokyo , 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6901-6364","authenticated-orcid":false,"given":"Ryosuke","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Institute of Science Tokyo , 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519 ,","place":["Japan"]},{"name":"Department of Cardiovascular Medicine, Akita University Graduate School of Medicine , Akita 010-0041 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwanari","family":"Kawamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Institute of Science Tokyo , 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Toda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Institute of Science Tokyo , 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1247-8442","authenticated-orcid":false,"given":"Masaki","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Institute of Science Tokyo , 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4791-2864","authenticated-orcid":false,"given":"Miho","family":"Negishi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Institute of Science Tokyo , 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Tateishi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Institute of Science Tokyo , 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9324-9603","authenticated-orcid":false,"given":"Junji","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Institute of Science Tokyo , 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Institute of Science Tokyo , 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Institute of Science Tokyo , 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6733-3780","authenticated-orcid":false,"given":"Susumu","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Institute of Science Tokyo , 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Institute of Science Tokyo , 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3582-6104","authenticated-orcid":false,"given":"Tetsuo","family":"Sasano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Institute of Science Tokyo , 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"2026100816025007000_oeag124-B1","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/jce.13454","article-title":"Irreversible electroporation ablation for atrial fibrillation","volume":"29","author":"Wojtaszczyk","year":"2018","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026100816025007000_oeag124-B2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.jacep.2018.04.005","article-title":"Ablation of atrial fibrillation with pulsed electric fields: an ultra-rapid, tissue-selective modality for cardiac ablation","volume":"4","author":"Reddy","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"2026100816025007000_oeag124-B3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jacc.2019.04.021","article-title":"Pulsed field ablation for pulmonary vein isolation in atrial fibrillation","volume":"74","author":"Reddy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026100816025007000_oeag124-B4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007781","article-title":"Preclinical evaluation of pulsed field ablation: electrophysiological and histological assessment of thoracic vein isolation","volume":"12","author":"Koruth","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026100816025007000_oeag124-B5","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1161\/CIRCULATIONAHA.123.063988","article-title":"Pulsed field ablation for the treatment of atrial fibrillation: PULSED AF pivotal trial","volume":"147","author":"Verma","year":"2023","journal-title":"Circulation"},{"key":"2026100816025007000_oeag124-B6","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jacc.2020.07.007","article-title":"Pulsed field ablation in patients with persistent atrial fibrillation","volume":"76","author":"Reddy","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026100816025007000_oeag124-B7","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/CIRCULATIONAHA.124.070333","article-title":"Pulsed field ablation to treat paroxysmal atrial fibrillation: safety and effectiveness in the AdmIRE pivotal trial","volume":"150","author":"Reddy","year":"2024","journal-title":"Circulation"},{"key":"2026100816025007000_oeag124-B8","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMoa2307291","article-title":"Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation","volume":"389","author":"Reddy","year":"2023","journal-title":"N Engl J Med"},{"key":"2026100816025007000_oeag124-B9","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.hrthm.2010.12.023","article-title":"The Heart Rhythm Society (HRS)\/American Society of Anesthesiologists (ASA) expert consensus statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors","volume":"8","author":"Crossley","year":"2011","journal-title":"Heart Rhythm"},{"key":"2026100816025007000_oeag124-B10","doi-asserted-by":"crossref","DOI":"10.1007\/s10840-024-01758-2","article-title":"Pulsed field ablation in patients with cardiac implantable electronic devices: an ex vivo assessment of safety","author":"Lennerz","year":"2024","journal-title":"J Interv Card Electrophysiol"},{"key":"2026100816025007000_oeag124-B11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.hrcr.2024.10.018","article-title":"Safety of pulsed field ablation using a circular catheter in a patient with a cardiac implantable electronic device","volume":"11","author":"Iqbal","year":"2024","journal-title":"HeartRhythm Case Rep"},{"key":"2026100816025007000_oeag124-B12","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.hrcr.2024.08.020","article-title":"Pulsed field ablation can be a source of electromagnetic interference with cardiac implantable electronic devices","volume":"10","author":"Liu","year":"2024","journal-title":"HeartRhythm Case Rep"},{"key":"2026100816025007000_oeag124-B13","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euaf153","article-title":"Pulsed field ablation in cardiac implantable electronic device patients: a welcome advance, yet questions remain","volume":"27","author":"Karakasis","year":"2025","journal-title":"Europace"},{"key":"2026100816025007000_oeag124-B14","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.hrcr.2024.08.006","article-title":"A novel etiology for automatic mode switching and ventricular noise reversion alerts: pulsed field ablation","volume":"10","author":"Lampert","year":"2024","journal-title":"HeartRhythm Case Rep"},{"key":"2026100816025007000_oeag124-B15","first-page":"2022","article-title":"Pulsed-field ablation and device-device procedural interactions with cardiac implantable electronic devices","volume":"6","author":"Abdelsayed","year":"2025","journal-title":"Heart Rhythm O2"},{"key":"2026100816025007000_oeag124-B16","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.hrthm.2025.09.027","article-title":"Cardiac implantable electronic device software reset and damage after pulsed field ablation using a monopolar lattice-tip catheter","volume":"23","author":"Nair","year":"2025","journal-title":"Heart Rhythm"},{"key":"2026100816025007000_oeag124-B17","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.hrthm.2026.01.028","article-title":"Permanent damage to implantable cardioverter-defibrillators during left-sided septal ventricular tachycardia ablation using a lattice-tip catheter: a case series","volume":"23","author":"Malyar","year":"2026","journal-title":"Heart Rhythm"},{"key":"2026100816025007000_oeag124-B18","author":"Sachdev"},{"key":"2026100816025007000_oeag124-B19","doi-asserted-by":"crossref","first-page":"e1300","DOI":"10.1016\/j.hrthm.2025.07.055","article-title":"Visible arcing observed with pulsed field ablation applications delivered near a left atrial appendage occlusion device","volume":"22","author":"Campos-Villarreal","year":"2025","journal-title":"Heart Rhythm"},{"key":"2026100816025007000_oeag124-B20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.hrcr.2025.12.012","article-title":"Irreversible intracardiac defibrillator circuit damage induced by pulsed-field ablation: mechanistic insights","volume":"12","author":"Takahashi","year":"2026","journal-title":"HeartRhythm Case Rep"},{"key":"2026100816025007000_oeag124-B21","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1109\/TBME.2006.889196","article-title":"Feasibility of employing model-based optimization of pulse amplitude and electrode distance for effective tumor electropermeabilization","volume":"54","author":"Sel","year":"2007","journal-title":"IEEE Trans Biomed Eng"},{"key":"2026100816025007000_oeag124-B22","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1529\/biophysj.104.048975","article-title":"Effect of cell electroporation on the conductivity of a cell suspension","volume":"88","author":"Pavlin","year":"2005","journal-title":"Biophys J"},{"key":"2026100816025007000_oeag124-B23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1475-925X-12-16","article-title":"Modeling of electric field distribution in tissues during electroporation","volume":"12","author":"Corovi\u0107","year":"2013","journal-title":"Biomed Eng Online"},{"key":"2026100816025007000_oeag124-B24","first-page":"739","article-title":"Electrical conductivity changes during irreversible electroporation treatment of brain cancer","volume":"2011","author":"Garcia","year":"2011","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"2026100816025007000_oeag124-B25","doi-asserted-by":"crossref","first-page":"13517","DOI":"10.1038\/s41598-020-70308-3","article-title":"Effect of irreversible electroporation parameters and the presence of a metal stent on the electric field line pattern","volume":"10","author":"Hogenes","year":"2020","journal-title":"Sci Rep"},{"key":"2026100816025007000_oeag124-B26","article-title":"Epicardial pulsed-field ablation: impact of electric field and heat distribution induced by coronary metallic stents","volume":"11","author":"Wang","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"2026100816025007000_oeag124-B27","doi-asserted-by":"crossref","first-page":"18719","DOI":"10.1038\/s41598-025-01965-5","article-title":"Effects of electric field and heat distribution due to trends in metal stent diameter in epicardial pulsed field ablation","volume":"15","author":"Wang","year":"2025","journal-title":"Sci Rep"},{"key":"2026100816025007000_oeag124-B28","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/jce.70259","article-title":"Acute atrial pacing threshold elevation in an auricular leadless pacemaker during monopolar pulsed field ablation of the right inferior pulmonary vein: a first-in-human case","volume":"37","author":"D\u00edaz","year":"2026","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026100816025007000_oeag124-B29","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.hrcr.2025.08.005","article-title":"A case of near-zero fluoroscopy ablation using a circular catheter in a patient with a dual-chamber leadless pacemaker","volume":"11","author":"Kikuchi","year":"2025","journal-title":"HeartRhythm Case Rep"},{"key":"2026100816025007000_oeag124-B30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.125.013911","article-title":"Real-time prediction of irreversible lesion size during pulsed field ablation: prospective validation of a novel ablation Index based on contact force and number of applications in a swine beating heart model","volume":"18","author":"Nakagawa","year":"2025","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026100816025007000_oeag124-B31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0287614","article-title":"How intramyocardial fat can alter the electric field distribution during Pulsed Field Ablation (PFA): qualitative findings from computer modeling","volume":"18","author":"P\u00e9rez","year":"2023","journal-title":"PLoS One"},{"key":"2026100816025007000_oeag124-B32","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.hrthm.2025.02.017","article-title":"Dose-dependent ventricular lesion formation using a novel large-area pulsed field ablation catheter: a preclinical feasibility study","volume":"22","author":"Kueffer","year":"2025","journal-title":"Heart Rhythm"}],"container-title":["European Heart Journal Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/6\/5\/oeag124\/71033183\/oeag124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjopen\/article-pdf\/6\/5\/oeag124\/71033183\/oeag124.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:03:02Z","timestamp":1791489782000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjopen\/article\/doi\/10.1093\/ehjopen\/oeag124\/8790649"}},"subtitle":[],"editor":[{"given":"Daniel F J","family":"Ketelhuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjopen\/oeag124","relation":{},"ISSN":["2752-4191"],"issn-type":[{"value":"2752-4191","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,9]]},"article-number":"oeag124"}}